• Symposium Objectives

    The Symposium objectives are presenting the most significant achievements in the development and practical application of computational methods in discovery and validation of new drug targets, in silico design of more efficient and safer pharmaceutical substances, optimization of their structures and properties, rational utilization of therapeutics in medical practice, as well as discussing the current trends in this multidisciplinary field.

  • Key dates

    28 January – 2 April: Registration.

    28 January – 14 March: Abstract submission

    20 March: Publication of the symposium program

    5 – 7 April: Symposium

  • Online Meeting

    Due to the ongoing COVID-19 pandemic, the XXVII Symposium on Bioinformatics and Computer-Aided Drug Discovery was held online on April 5-7, 2021. PDF presentations are availible on the Symposium website.

About Symposium

Symposia on Bioinformatics and Computer-Aided Drug Discovery have been held since 1995 at the initiative of the Full Member of Russian Academy of Sciences Alexander Archakov in the framework of the Russian National Congresses “Man and Drugs”.

A.I. Archakov and V.V. Poroikov co-chaired the first one, which was held in the framework of the Second Russian National Congress “Man and Drugs” (Moscow, 12-15 April 1995). The next Symposia were being organized annually by the Full Member of Russian Academy of Sciences Nikolai Zefirov and Professor Vladimir Poroikov. Since 2018 Profs. Vladimir Poroikov and Roman Efremov have been Symposium Co-Chairs.

Initially, we had been organizing this Symposium in the framework of the Russian National Congresses “Man and Drugs”. A three-hour session was being held at the Congress facilities, at the Russian Presidential Academy of National Economy and Public Administration on Vernadsky Avenue at first, and then at World Trade Center on Krasnaya Presnya. On the second day, several sessions, including the Young Scientists’ Contest by oral presentations, were being held using facilities of the Institute of Biomedical Chemistry (IBMC). All sessions had been included in the Congress Program, allowing participants to receive timely information and listen to the talks of interest.

This tradition was broken in 2019 when the information about Symposium events held in IBMC had not been included in the Congress Program for the first time. In 2020, Symposium was utterly left out of the Congress Program due to the coronavirus pandemics, and we performed it online on April 6-25. All information, including lecture presentations, video of some reports, proceedings of discussion, and information about Young Scientists’ Contest Awards, is available on the IBMC website.

In 2021, the XXVII Symposium on Bioinformatics and Computer-Aided Drug Discovery will be held online with international participation during 3 days in the form of oral presentations using one of the cloud video conferencing platforms. Currently, we tested such a mode of meetings, and additional feasibilities became apparent. In particular, authoritative international researchers’ lectures are included in the Symposium’s Program and will be presented online. The Young Scientists’ Contest will be conducted as a part of the Symposium, and Diplomas will award the winners.

In 1995–2020 many prominent Russian and foreign scientists working in this field have presented the lectures at the Symposia, including Nikolai Zefirov (Faculty of Chemistry, MSU, Moscow), Oleg Raevsky (Institute of Physiologically Active Substances, Chernogolovka), Vladimir Tumanyan and Natalia Esipova (Institute of Molecular Biology, Moscow), Victor Finn (VINITI, Moscow), Alexei Finkelstein (Institute of Protein Research, Pushchino), Mikhail Gelfand (Institute for Information Transmission Problems RAS, Moscow), Alexis Ivanov (Institute of Biomedical Chemistry, Moscow), Yury Vorobjev (Institute of Chemical Biology and Fundamental Medicine, Novosibirsk), Pavel Vassiliev (Volgograd State Medical University, Volgograd), Oxana Galzitskaya (Institute of Protein Research, Pushchino), Michael Petukhov (Petersburg Nuclear Physics Institute NRC, Saint Petersburg), Igor Baskin (Faculty of Physics, MSU, Moscow), Vladimir Sulimov (Research Computing Center, MSU, Moscow), Vladimir Turovtsev (Tver State University, Tver), Peter Fedichev (Quantum Pharmaceuticals, Moscow), Per Artursson (Uppsala University, Sweden), Oliver Steck and Andreas Witte (Tripos, Germany), Alexandre Varnek (University of Strasbourg, Strasbourg, France), Victor Kuz'min (A.V. Bogatsky Physical-Chemical Institute, Odessa, Ukraine), Anatoli Dimoglo (Institute of Technology, Gebze, Turkey), Dusanka Janezic (National Institute of Chemistry, Slovenia), Eric Weber (Environmental Protection Agency, USA), Eugene Kolker (The BIATECH Institute, USA), Alexander Kel (GeneXplain, Germany), Thomas Steinbrecher (Schrödinger, Germany), and others.

Local organising committee

E-mail: bioinfo@way2drug.com